<b>Conclusions:</b> Combination therapy with UC-MSCs and secretome may have potential to improve metabolic profiles through increasing adiponectin and improving insulin sensitivity in PCOS patients, especially in the group with insulin resistance. Here, INS is linked to polycystic ovary syndrome.